North America Proton Therapy Market Size, Share & Industry Trends Analysis Report By Product Type, By Indication (CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Others), By End User, By Country and Growth Forecast, 2022 - 2028

The North America Proton Therapy Market is expected to witness market growth of 11.8% CAGR during the forecast period (2022-2028).

Proton therapy (PT) is being quickly adopted by the oncology field to enhance the effectiveness of various cancer treatments. PT has been shown to have advantages in the rate of local tumor therapy and reduced radiation-induced side effects, which increases patient survival rates in general. The enormous potential of proton beam treatment has sparked the growth of PT facilities and the use of pricey equipment, propelling the development of the PT market.

In many cancer types, proton beam therapy is quickly replacing traditional radiation therapy as a potent and superior option. Proton treatment is a sort of proton therapy used in medicine to irradiate diseased tissue - most frequently, cancerous tissue. The main benefit of proton therapy over other forms of external beam irradiation is that the dose of protons is placed across a constrained depth range, resulting in low radiation dose entry, exit, or dispersion to healthy adjacent tissues.

In 2019, 16.32% of North America's GDP was allocated to healthcare. The market is expanding as a result of factors like technological advancement and the development of fewer human glioblastoma treatment options in industrialized nations. According to the National Cancer Institute of the US Department of Health and Human Services, one in sixteen Americans may require treatment for lung cancer over their lifetime.

The US market dominated the North America Proton Therapy Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $267,367.2 Thousands by 2028. The Canada market is experiencing a CAGR of 14.3% during (2022 - 2028). Additionally, The Mexico market is exhibiting a CAGR of 13.3% during (2022 - 2028).

Based on Product Type, the market is segmented into Accelerator, Beam Delivery System, Beam Transport System, Nozzle & Image Viewers and Patient Positioning System. Based on Indication, the market is segmented into CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Others. Based on End User, the market is segmented into Hospitals, Proton Therapy Centers and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Toshiba Corporation, Siemens Healthineers AG (Siemens AG), Ion Beam Applications SA, Hitachi, Ltd., Mirion Technologies, Inc., Mevion Medical Systems, Inc., Provision Healthcare, Sumitomo Corporation and Optivus Proton Therapy, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Product Type

• Accelerator
• Beam Delivery System
• Beam Transport System
• Nozzle & Image Viewers
• Patient Positioning System

By Indication

• CNS Cancer
• Prostate Cancer
• Head & Neck Cancer
• Breast Cancer
• Others

By End User

• Hospitals
• Proton Therapy Centers
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• Toshiba Corporation
• Siemens Healthineers AG (Siemens AG)
• Ion Beam Applications SA
• Hitachi, Ltd.
• Mirion Technologies, Inc.
• Mevion Medical Systems, Inc.
• Provision Healthcare
• Sumitomo Corporation
• Optivus Proton Therapy, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free